| Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders B Viollet, M Foretz, B Guigas, S Horman, R Dentin, L Bertrand, L Hue, ... The Journal of physiology 574 (1), 41-53, 2006 | 650 | 2006 |
| Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis S Horman, GJ Browne, U Krause, JV Patel, D Vertommen, L Bertrand, ... Current biology 12 (16), 1419-1423, 2002 | 555 | 2002 |
| AMPK inhibition in health and disease B Viollet, S Horman, J Leclerc, L Lantier, M Foretz, M Billaud, S Giri, ... Critical reviews in biochemistry and molecular biology 45 (4), 276-295, 2010 | 480 | 2010 |
| Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491 S Horman, D Vertommen, R Heath, D Neumann, V Mouton, A Woods, ... Journal of Biological Chemistry 281 (9), 5335-5340, 2006 | 406 | 2006 |
| Insulin signalling in the heart L Bertrand, S Horman, C Beauloye, JL Vanoverschelde Cardiovascular research 79 (2), 238-248, 2008 | 360 | 2008 |
| AMPK: Lessons from transgenic and knockout animals B Viollet, Y Athea, R Mounier, B Guigas, E Zarrinpashneh, S Horman, ... Frontiers in bioscience (Landmark edition) 14, 19, 2009 | 354 | 2009 |
| AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure C Beauloye, L Bertrand, S Horman, L Hue Cardiovascular research 90 (2), 224-233, 2011 | 213 | 2011 |
| AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation R Gélinas, F Mailleux, J Dontaine, L Bultot, B Demeulder, A Ginion, ... Nature communications 9 (1), 374, 2018 | 189 | 2018 |
| Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2 S Horman, C Beauloye, D Vertommen, JL Vanoverschelde, L Hue, ... Journal of Biological Chemistry 278 (43), 41970-41976, 2003 | 149 | 2003 |
| AMP-activated Protein Kinase Phosphorylates and Desensitizes Smooth Muscle Myosin Light Chain Kinase*♦ S Horman, N Morel, D Vertommen, N Hussain, D Neumann, C Beauloye, ... Journal of Biological Chemistry 283 (27), 18505-18512, 2008 | 143 | 2008 |
| Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways L Hue, C Beauloye, AS Marsin, L Bertrand, S Horman, MH Rider Journal of molecular and cellular cardiology 34 (9), 1091-1097, 2002 | 135 | 2002 |
| NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1 M Balteau, N Tajeddine, C De Meester, A Ginion, C Des Rosiers, ... Cardiovascular research 92 (2), 237-246, 2011 | 130 | 2011 |
| AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation EP Daskalopoulos, C Dufeys, L Bertrand, C Beauloye, S Horman Journal of Molecular and Cellular Cardiology 91, 188-200, 2016 | 121 | 2016 |
| AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes M Balteau, A Van Steenbergen, AD Timmermans, C Dessy, ... American Journal of Physiology-Heart and Circulatory Physiology 307 (8 …, 2014 | 113 | 2014 |
| AMP-activated protein kinase in the control of cardiac metabolism and remodeling S Horman, C Beauloye, JL Vanoverschelde, L Bertrand Current heart failure reports 9, 164-173, 2012 | 101 | 2012 |
| Antisense inhibition of the 27 kDa heat shock protein production affects growth rate and cytoskeletal organization in MCF-7 cells N Mairesse, S Horman, R Mosselmans, P Galand Cell biology international 20 (3), 205-212, 1996 | 98 | 1996 |
| Role of the α2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia E Zarrinpashneh, K Carjaval, C Beauloye, A Ginion, P Mateo, AC Pouleur, ... American Journal of Physiology-Heart and Circulatory Physiology 291 (6 …, 2006 | 97 | 2006 |
| Regulation of carbohydrate metabolism, lipid metabolism, and protein metabolism by AMPK Y Angin, C Beauloye, S Horman, L Bertrand AMP-Activated Protein Kinase, 23-43, 2016 | 90 | 2016 |
| HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome N Hermida, A Markl, J Hamelet, T Van Assche, A Vanderper, P Herijgers, ... Cardiovascular research 99 (1), 44-54, 2013 | 88 | 2013 |
| Chronic intermittent hypoxia impairs insulin sensitivity but improves whole-body glucose tolerance by activating skeletal muscle AMPK A Thomas, E Belaidi, S Moulin, S Horman, GC van der Zon, B Viollet, ... Diabetes 66 (12), 2942-2951, 2017 | 85 | 2017 |
